Literature DB >> 35640676

Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines.

Abdulkadir Isidan1, Ali Yenigun2, Daiki Soma3, Eric Aksu1, Kevin Lopez1, Yujin Park1, Arthur Cross-Najafi1, Ping Li1, Debjyoti Kundu4, Michael G House5, Sanjukta Chakraborty6, Shannon Glaser6, Lindsey Kennedy4, Heather Francis4, Wenjun Zhang1, Gianfranco Alpini4, Burcin Ekser7.   

Abstract

Cholangiocarcinoma (CCA) is the second most common primary liver tumor and is associated with late diagnosis, limited treatment options, and a 5-year survival rate of around 30%. CCA cell lines were first established in 1971, and since then, only 70 to 80 CCA cell lines have been established. These cell lines have been essential in basic and translational research to understand and identify novel mechanistic pathways, biomarkers, and disease-specific genes. Each CCA cell line has unique characteristics, reflecting a specific genotype, sex-related properties, and patient-related signatures, making them scientifically and commercially valuable. CCA cell lines are crucial in the use of novel technologies, such as three-dimensional organoid models, which help to model the tumor microenvironment and cell-to-cell crosstalk between tumor-neighboring cells. This review highlights crucial information on CCA cell lines, including: i) type of CCA (eg, intra- or extrahepatic), ii) isolation source (eg, primary tumor or xenograft), iii) chemical digestion method (eg, trypsin or collagenase), iv) cell-sorting method (colony isolation or removal of fibroblasts), v) maintenance-medium choice (eg, RPMI or Dulbecco's modified Eagle's medium), vi) cell morphology (eg, spindle or polygonal shape), and vii) doubling time of cells.
Copyright © 2022 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35640676      PMCID: PMC9472155          DOI: 10.1016/j.ajpath.2022.05.007

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   5.770


  89 in total

1.  The invasion potentials of human biliary tract carcinoma cell lines: correlation between invasiveness and morphologic characteristics.

Authors:  N Koike; T Todoroki; T Kawamoto; S Yoshida; H Kashiwagi; K Fukao; T Ohno; T Watanabe
Journal:  Int J Oncol       Date:  1998-12       Impact factor: 5.650

2.  Chromosomal breakpoints in cholangiocarcinoma cell lines.

Authors:  P D Storto; S L Saidman; A J Demetris; E Letessier; T L Whiteside; S M Gollin
Journal:  Genes Chromosomes Cancer       Date:  1990-11       Impact factor: 5.006

Review 3.  Cell cross-contamination in cell cultures: the silent and neglected danger.

Authors:  O Markovic; N Markovic
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-01       Impact factor: 2.416

Review 4.  Cholangiocarcinoma: novel therapeutic targets.

Authors:  Keisaku Sato; Shannon Glaser; Domenico Alvaro; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Expert Opin Ther Targets       Date:  2020-02-26       Impact factor: 6.902

5.  Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium.

Authors:  H Nakabayashi; K Taketa; T Yamane; M Miyazaki; K Miyano; J Sato
Journal:  Gan       Date:  1984-02

6.  A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium.

Authors:  M Miyagiwa; T Ichida; T Tokiwa; J Sato; H Sasaki
Journal:  In Vitro Cell Dev Biol       Date:  1989-06

7.  Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment.

Authors:  Hidenori Ojima; Daitaro Yoshikawa; Yoshihiro Ino; Hiroko Shimizu; Masashi Miyamoto; Akiko Kokubu; Nobuyoshi Hiraoka; Noriaki Morofuji; Tadashi Kondo; Hiroaki Onaya; Takuji Okusaka; Kazuaki Shimada; Yoshihiro Sakamoto; Minoru Esaki; Satoshi Nara; Tomoo Kosuge; Setsuo Hirohashi; Yae Kanai; Tatsuhiro Shibata
Journal:  Cancer Sci       Date:  2009-12-08       Impact factor: 6.716

Review 8.  The Tumor Microenvironment in Cholangiocarcinoma Progression.

Authors:  Luca Fabris; Keisaku Sato; Gianfranco Alpini; Mario Strazzabosco
Journal:  Hepatology       Date:  2020-11-06       Impact factor: 17.298

9.  Establishment of a new human extrahepatic bile duct carcinoma cell line (OCUCh-LM1) and experimental liver metastatic model.

Authors:  N Yamada; Y S Chung; Y Arimoto; T Sawada; S Seki; M Sowa
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

Review 10.  Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma.

Authors:  Burcin Ekser; Gianfranco Alpini; Keisaku Sato; Wenjun Zhang; Samira Safarikia; Abdulkadir Isidan; Angela M Chen; Ping Li; Heather Francis; Lindsey Kennedy; Leonardo Baiocchi; Domenico Alvaro; Shannon Glaser
Journal:  Hepatology       Date:  2021-06-04       Impact factor: 17.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.